ANDA 90088, held by Fresenius Kabi USA. Anastrozole.
As of Nov 16, 2026, ANDA 90088 (Anastrozole), held by Fresenius Kabi USA, was first approved by FDA on Jun 28, 2010, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 2010 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Anastrozole1MG ยท tablet;oral | Anastrozole | Discontinued |
| Nov 22, 2011 | Supplement 2Labeling | Approved | None posted |
| Mar 16, 2011 | Supplement 1Labeling | Approved | None posted |
| Jun 28, 2010 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters